Tiazofurin
![]() | |
Clinical data | |
---|---|
ATC code | L01XX18 (WHO) |
Identifiers | |
| |
Synonyms | 2-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-thiazole-4-carboxamide |
CAS Number |
60084-10-8 ![]() |
PubChem (CID) | 457954 |
ChemSpider |
403014 ![]() |
UNII |
ULJ82834RE ![]() |
ChEMBL |
CHEMBL108358 ![]() |
Chemical and physical data | |
Formula | C9H12N2O5S |
Molar mass | 260.268 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
![]() ![]() |
Tiazofurin is an inhibitor of IMP dehydrogenase. Tiazofurin and its analogues are under investigation for potential use in the treatment of cancer.[1]
References
- ↑ Popsavin M, Torović L, Svircev M, et al. (2006). "Synthesis and antiproliferative activity of two new tiazofurin analogues with 2'-amido functionalities". Bioorg. Med. Chem. Lett. 16 (10): 2773–6. doi:10.1016/j.bmcl.2006.02.001. PMID 16495053.
This article is issued from Wikipedia - version of the 9/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.